Reflect Scientific, Inc.
RSCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 1.88 | -0.04 | 0.44 |
| FCF Yield | 0.00% | 0.00% | 1.58% | 0.00% |
| EV / EBITDA | 62.01 | -247.27 | 41.88 | 2,330.05 |
| Quality | ||||
| ROIC | 1.32% | -0.70% | 2.09% | -1.20% |
| Gross Margin | 57.32% | 64.38% | 38.59% | 16.90% |
| Cash Conversion Ratio | 1.15 | -0.66 | 0.03 | 5.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.53% | 11.13% | 5.92% | -2.76% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -30.39 | 73.53 | -12.19 | -703.59 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.22 | 0.14 | 0.32 | 0.40 |
| Cash Conversion Cycle | 397.20 | 706.08 | 343.68 | 288.13 |